Vergoeding 2015-2019 voor ATC-subgroep G04CA : Alfa-blokkers
- Raming voor de totale Zvw-populatie
| 2015 | 2016 | 2017 | 2018 | 2019 | |
|---|---|---|---|---|---|
| G04CA01 Alfuzosine (Xatral ®) | 958.920 | 935.520 | 925.580 | 899.180 | 909.350 |
| G04CA02 Tamsulosine (Omnic ®) | 2.158.200 | 2.026.700 | 1.982.900 | 2.009.500 | 2.016.000 |
| G04CA03 Terazosine (Hytrin ®) | 81.973 | 75.563 | 63.063 | 57.112 | 56.983 |
| G04CA04 Silodosine (Silodyx ®) | 571.590 | 661.350 | 791.840 | 875.780 | 932.180 |
| G04CA52 Tamsulosine met dutasteride (Combodart ®) | 7.919.000 | 8.118.800 | 8.698.400 | 9.042.700 | 9.077.000 |
| G04CA53 Tamsulosine met solifenacine (Vesomni ®) | 1.626.800 | 2.142.800 | 2.649.500 | 2.961.000 | 3.331.000 |
| Totaal | 13.316.483 | 13.960.733 | 15.111.283 | 15.845.272 | 16.322.513 |